Sector Gamma As buys $29,583,261 stake in PerkinElmer (PKI)

PerkinElmer (PKI) : Sector Gamma As scooped up 44,680 additional shares in PerkinElmer during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 11, 2016. The investment management firm now holds a total of 543,710 shares of PerkinElmer which is valued at $29,583,261.PerkinElmer makes up approximately 5.66% of Sector Gamma As’s portfolio.

Other Hedge Funds, Including , Rhumbline Advisers boosted its stake in PKI in the latest quarter, The investment management firm added 11,472 additional shares and now holds a total of 143,916 shares of PerkinElmer which is valued at $7,830,470. PerkinElmer makes up approx 0.02% of Rhumbline Advisers’s portfolio.Blackrock Fund Advisors boosted its stake in PKI in the latest quarter, The investment management firm added 12,067 additional shares and now holds a total of 1,743,937 shares of PerkinElmer which is valued at $94,887,612. PerkinElmer makes up approx 0.02% of Blackrock Fund Advisors’s portfolio. Ropes Wealth Advisors sold out all of its stake in PKI during the most recent quarter. The investment firm sold 24 shares of PKI which is valued $1,313.Calvert Investment Management boosted its stake in PKI in the latest quarter, The investment management firm added 474 additional shares and now holds a total of 6,820 shares of PerkinElmer which is valued at $374,077. PerkinElmer makes up approx 0.02% of Calvert Investment Management’s portfolio.Arcadia Investment Management Corpmi boosted its stake in PKI in the latest quarter, The investment management firm added 240 additional shares and now holds a total of 84,285 shares of PerkinElmer which is valued at $4,655,061. PerkinElmer makes up approx 1.47% of Arcadia Investment Management Corpmi’s portfolio.

PerkinElmer opened for trading at $55.28 and hit $56.24 on the upside on Tuesday, eventually ending the session at $55.94, with a gain of 1.52% or 0.84 points. The heightened volatility saw the trading volume jump to 6,19,397 shares. Company has a market cap of $6,120 M.

On the company’s financial health, PerkinElmer reported $0.67 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $0.66. The company had revenue of $573.00 million for the quarter, compared to analysts expectations of $575.66 million. The company’s revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.60 EPS.

Many Wall Street Analysts have commented on PerkinElmer. Mizuho Downgraded PerkinElmer on Aug 5, 2016 to ” Neutral”, Price Target of the shares are set at $56.

PerkinElmer Inc. is a provider of products services and solutions to the diagnostics research environmental industrial and laboratory services markets. The Company operates its business in two segments: Human Health and Environmental Health. The Company’s Human Health segment concentrates on developing diagnostics tools and applications to help detect diseases earlier and more accurately and to accelerate the discovery and development of new therapies. The Company’s Environmental Health segment provides products services and solutions to facilitate the creation of safer food and consumer products more secure surroundings and efficient energy resources. The Company markets its products and services in more than 150 countries.

Leave a Reply

PerkinElmer - Is it time to Sell?

Top Brokerage Firms are advising their investors on PerkinElmer. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.